MLYS Mineralys Therapeutics, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $1.4B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $44.1M | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $80.2K | $3.0M |
| 2023-Q4 | $25.4K | $0 |
| 2024-Q1 | $7.5M | $0 |
| 2024-Q2 | $0 | $2.8M |
| 2024-Q3 | $0 | $7.5M |
| 2024-Q4 | $0 | $810.8K |
| 2025-Q1 | $29.1M | $263.9K |
| 2025-Q2 | $0 | $1.7M |
| 2025-Q3 | $45.0M | $2.2M |
| 2025-Q4 | $0 | $61.6M |
| 2026-Q1 | $8.8M | $14.4M |
| 2026-Q2 | $0 | $7.0M |
| 2026-Q3 | $0 | $6.6M |
| 2026-Q4 | $0 | $0 |
Bought$134.6M17 buy days
Sold$107.8M91 sell days
Net insider flow+$26.8Mnet buying · 5 years
Latest trade2026-09-30Congleton Jon
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Sell | Congleton Jon | CEO | 75,000 | $25.46 | $1.9M | 1 |
| 2026-09-22 | Sell | Slingsby Brian Taylor | Director | 104,320 | $28.81 | $3.0M | 1 |
| 2026-09-21 | Sell | Warren Eric | Other C-suite | 7,438 | $28.12 | $209.1K | 1 |
| 2026-09-15 | Sell | Karydas Daphne | Director | 3,000 | $28.58 | $85.7K | 1 |
| 2026-08-21 | Sell | Warren Eric | Other C-suite | 7,437 | $25.98 | $193.2K | 1 |
| 2026-08-10 | Sell | Rodman David Malcom | Other C-suite | 2,170 | $27.09 | $58.8K | 1 |
| 2026-07-21 | Sell | Warren Eric | Other C-suite | 7,438 | $26.87 | $199.9K | 1 |
| 2026-07-17 | Sell | Rodman David Malcom | Other C-suite | 416 | $26.53 | $11.0K | 1 |
| 2026-07-15 | Sell | Rodman David Malcom | Other C-suite | 6,349 | $26.61 | $169.0K | 1 |
| 2026-07-13 | Sell | Rodman David Malcom | Other C-suite | 14,058 | $27.58 | $387.7K | 1 |
| 2026-07-13 | Sell | Congleton Jon | CEO | 10,700 | $27.24 | $291.4K | 1 |
| 2026-07-09 | Sell | Rodman David Malcom | Other C-suite | 2,171 | $30.30 | $65.8K | 1 |
| 2026-06-30 | Sell | Congleton Jon | CEO | 75,000 | $26.14 | $2.0M | 2 |
| 2026-06-26 | Sell | Warren Eric | Other C-suite | 104,124 | $25.90 | $2.7M | 1 |
| 2026-06-17 | Sell | Rodman David Malcom | Other C-suite | 4,584 | $25.00 | $114.6K | 1 |
| 2026-06-17 | Sell | Karydas Daphne | Director | 3,000 | $25.00 | $75.0K | 1 |
| 2026-06-15 | Sell | Rodman David Malcom | Other C-suite | 9,890 | $23.81 | $235.5K | 1 |
| 2026-06-12 | Sell | Rodman David Malcom | Other C-suite | 6,349 | $23.93 | $151.9K | 1 |
| 2026-06-10 | Sell | Rodman David Malcom | Other C-suite | 2,170 | $25.00 | $54.2K | 1 |
| 2026-05-18 | Sell | Rodman David Malcom | Other C-suite | 417 | $27.55 | $11.5K | 1 |
| 2026-05-13 | Sell | Rodman David Malcom | Other C-suite | 14,056 | $28.58 | $401.7K | 1 |
| 2026-05-12 | Sell | Rodman David Malcom | Other C-suite | 6,348 | $29.36 | $186.4K | 1 |
| 2026-05-11 | Sell | Rodman David Malcom | Other C-suite | 2,171 | $29.71 | $64.5K | 1 |
| 2026-04-17 | Sell | Rodman David Malcom | Other C-suite | 416 | $31.33 | $13.0K | 1 |
| 2026-04-15 | Sell | Rodman David Malcom | Other C-suite | 6,348 | $27.66 | $175.6K | 1 |
| 2026-04-13 | Sell | Congleton Jon | CEO | 15,730 | $26.83 | $422.0K | 1 |
| 2026-04-13 | Sell | Rodman David Malcom | Other C-suite | 14,058 | $26.54 | $373.1K | 1 |
| 2026-04-09 | Sell | Rodman David Malcom | Other C-suite | 2,170 | $27.38 | $59.4K | 1 |
| 2026-03-31 | Sell | Congleton Jon | CEO | 75,000 | $26.27 | $2.0M | 3 |
| 2026-03-31 | Sell | Karydas Daphne | Director | 3,000 | $25.00 | $75.0K | 1 |
| 2026-03-30 | Buy | Kolchinsky Peter | Director | 58,300 | $24.16 | $1.4M | 1 |
| 2026-03-27 | Buy | Kolchinsky Peter | Director | 310,700 | $23.67 | $7.4M | 1 |
| 2026-03-17 | Sell | Rodman David Malcom | Other C-suite | 417 | $25.65 | $10.7K | 1 |
| 2026-03-13 | Sell | Rodman David Malcom | Other C-suite | 14,058 | $26.26 | $369.2K | 3 |
| 2026-03-12 | Sell | Rodman David Malcom | Other C-suite | 6,348 | $27.37 | $173.7K | 1 |
| 2026-03-09 | Sell | Rodman David Malcom | Other C-suite | 2,171 | $26.84 | $58.3K | 1 |
| 2026-02-17 | Sell | Rodman David Malcom | Other C-suite | 417 | $27.59 | $11.5K | 1 |
| 2026-02-13 | Sell | Rodman David Malcom | Other C-suite | 14,055 | $27.44 | $385.7K | 3 |
| 2026-02-12 | Sell | Rodman David Malcom | Other C-suite | 6,349 | $29.00 | $184.1K | 2 |
| 2026-02-09 | Sell | Rodman David Malcom | Other C-suite | 2,171 | $30.21 | $65.6K | 1 |
| 2026-01-20 | Sell | Rodman David Malcom | Other C-suite | 416 | $32.10 | $13.4K | 1 |
| 2026-01-14 | Sell | Rodman David Malcom | Other C-suite | 11,367 | $32.61 | $370.7K | 1 |
| 2026-01-13 | Sell | Rodman David Malcom | Other C-suite | 7,709 | $32.75 | $252.5K | 1 |
| 2026-01-12 | Sell | Congleton Jon | CEO | 16,236 | $32.62 | $529.7K | 2 |
| 2026-01-12 | Sell | Levy Adam Scott | CFO | 10,758 | $32.14 | $345.8K | 1 |
| 2026-01-12 | Sell | Rodman David Malcom | Other C-suite | 6,348 | $32.32 | $205.2K | 1 |
| 2026-01-09 | Sell | Rodman David Malcom | Other C-suite | 2,170 | $33.27 | $72.2K | 1 |
| 2026-01-05 | Sell | Rodman David Malcom | Other C-suite | 192,715 | $35.02 | $6.7M | 2 |
| 2026-01-02 | Sell | Rodman David Malcom | Other C-suite | 70,037 | $35.87 | $2.5M | 1 |
| 2025-11-20 | Sell | Slingsby Brian Taylor | Director | 1,000,000 | $43.35 | $43.4M | 1 |
| 2025-11-13 | Sell | Karydas Daphne | Director | 15,000 | $45.99 | $689.8K | 2 |
| 2025-11-13 | Sell | Gold Alexander M | Director | 12,742 | $46.50 | $592.5K | 1 |
| 2025-11-12 | Sell | Gold Alexander M | Director | 6,933 | $46.72 | $323.9K | 2 |
| 2025-11-11 | Sell | Congleton Jon | CEO | 200,000 | $45.44 | $9.1M | 6 |
| 2025-11-11 | Sell | Levy Adam Scott | CFO | 119,524 | $44.87 | $5.4M | 9 |
| 2025-11-11 | Sell | Gold Alexander M | Director | 15,000 | $43.98 | $659.7K | 2 |
| 2025-10-15 | Sell | Rodman David Malcom | Other C-suite | 10,369 | $43.01 | $446.0K | 1 |
| 2025-10-13 | Sell | Congleton Jon | CEO | 15,100 | $42.67 | $644.3K | 2 |
| 2025-10-13 | Sell | Levy Adam Scott | CFO | 10,758 | $42.01 | $452.0K | 2 |
| 2025-09-15 | Sell | Rodman David Malcom | Other C-suite | 11,367 | $36.00 | $409.3K | 2 |
| 2025-09-04 | Buy | Kolchinsky Peter | Director | 1,176,470 | $25.50 | $30.0M | 1 |
| 2025-09-04 | Buy | AKKARAJU SRINIVAS | Director | 588,235 | $25.50 | $15.0M | 1 |
| 2025-08-13 | Sell | Rodman David Malcom | Other C-suite | 11,365 | $12.93 | $146.9K | 1 |
| 2025-07-30 | Sell | Levy Adam Scott | CFO | 59,925 | $14.76 | $884.3K | 2 |
| 2025-07-29 | Sell | Levy Adam Scott | CFO | 807 | $14.00 | $11.3K | 1 |
| 2025-07-28 | Sell | Levy Adam Scott | CFO | 12,946 | $14.04 | $181.8K | 1 |
| 2025-07-14 | Sell | Rodman David Malcom | Other C-suite | 11,366 | $14.59 | $165.8K | 1 |
| 2025-07-11 | Sell | Congleton Jon | CEO | 15,884 | $14.51 | $230.5K | 1 |
| 2025-07-11 | Sell | Levy Adam Scott | CFO | 10,758 | $14.45 | $155.5K | 1 |
| 2025-06-13 | Sell | Rodman David Malcom | Other C-suite | 11,366 | $14.60 | $165.9K | 1 |
| 2025-05-14 | Sell | Rodman David Malcom | Other C-suite | 11,366 | $15.29 | $173.8K | 1 |
| 2025-04-14 | Sell | Rodman David Malcom | Other C-suite | 11,366 | $14.53 | $165.2K | 2 |
| 2025-04-11 | Sell | Congleton Jon | CEO | 15,319 | $12.19 | $186.7K | 1 |
| 2025-04-11 | Sell | Levy Adam Scott | CFO | 10,757 | $12.06 | $129.7K | 1 |
| 2025-04-01 | Sell | Rodman David Malcom | Other C-suite | 55,771 | $15.76 | $879.1K | 3 |
| 2025-03-13 | Buy | Kolchinsky Peter | Director | 1,296,296 | $13.50 | $17.5M | 1 |
| 2025-03-13 | Buy | Samsara BioCapital, L.P. | 10% owner | 600,000 | $13.50 | $8.1M | 1 |
| 2025-03-13 | Buy | Slingsby Brian Taylor | Director | 259,259 | $13.50 | $3.5M | 1 |
| 2025-01-13 | Sell | Congleton Jon | CEO | 18,333 | $9.06 | $166.1K | 1 |
| 2025-01-13 | Sell | Levy Adam Scott | CFO | 10,757 | $9.10 | $97.8K | 2 |
| 2024-11-11 | Sell | Rodman David Malcom | Other C-suite | 5,026 | $15.00 | $75.4K | 1 |
| 2024-11-06 | Sell | Rodman David Malcom | Other C-suite | 25,482 | $15.03 | $383.0K | 1 |
| 2024-10-11 | Sell | Congleton Jon | CEO | 15,271 | $13.52 | $206.5K | 1 |
| 2024-10-11 | Sell | Levy Adam Scott | CFO | 10,757 | $13.57 | $146.0K | 1 |
| 2024-07-24 | Sell | Slingsby Brian Taylor | Director | 550,000 | $13.05 | $7.2M | 1 |
| 2024-07-16 | Sell | Rodman David Malcom | Other C-suite | 525 | $15.00 | $7.9K | 1 |
| 2024-07-11 | Sell | Congleton Jon | CEO | 15,746 | $13.34 | $210.1K | 1 |
| 2024-07-11 | Sell | Levy Adam Scott | CFO | 10,757 | $13.14 | $141.3K | 1 |
| 2024-06-20 | Sell | Congleton Jon | CEO | 14,940 | $11.73 | $175.2K | 1 |
| 2024-06-18 | Sell | Congleton Jon | CEO | 16,607 | $11.99 | $199.1K | 1 |
| 2024-06-17 | Sell | Congleton Jon | CEO | 17,766 | $12.25 | $217.6K | 1 |
| 2024-06-14 | Sell | Congleton Jon | CEO | 16,229 | $12.52 | $203.2K | 1 |
| 2024-06-13 | Sell | Congleton Jon | CEO | 39,961 | $12.74 | $509.1K | 1 |
| 2024-06-12 | Sell | Congleton Jon | CEO | 16,607 | $12.77 | $212.1K | 1 |
| 2024-06-11 | Sell | Levy Adam Scott | CFO | 96,815 | $12.94 | $1.3M | 1 |
| 2024-05-09 | Sell | Rodman David Malcom | Other C-suite | 100 | $15.00 | $1.5K | 1 |
| 2024-02-12 | Buy | Samsara BioCapital, L.P. | 10% owner | 555,555 | $13.50 | $7.5M | 1 |
| 2023-11-22 | Buy | Congleton Jon | CEO | 4,250 | $5.97 | $25.4K | 1 |
| 2023-09-06 | Buy | Congleton Jon | CEO | 2,250 | $12.08 | $27.2K | 1 |
| 2023-08-17 | Buy | Congleton Jon | CEO | 2,250 | $12.10 | $27.2K | 1 |
| 2023-08-11 | Sell | Rodman David Malcom | Other C-suite | 157,091 | $12.81 | $2.0M | 2 |
| 2023-08-11 | Buy | Congleton Jon | CEO | 2,000 | $12.89 | $25.8K | 1 |
| 2023-08-10 | Sell | Rodman David Malcom | Other C-suite | 74,625 | $13.16 | $982.1K | 1 |
| 2023-02-14 | Buy | Kolchinsky Peter | Director | 1,250,000 | $16.00 | $20.0M | 2 |
| 2023-02-14 | Buy | AKKARAJU SRINIVAS | Director | 937,500 | $16.00 | $15.0M | 1 |
| 2023-02-14 | Buy | HBM Healthcare Investments (Cayman) Ltd. | 10% owner | 312,500 | $16.00 | $5.0M | 1 |
| 2023-02-14 | Buy | Slingsby Brian Taylor | Director | 250,000 | $16.00 | $4.0M | 1 |
| 2023-02-14 | Buy | Levy Adam Scott | CFO | 6,250 | $16.00 | $100.0K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Kolchinsky Peter | Director | $76.3M | $0 | 2026-03-30 |
| Slingsby Brian Taylor | Director | $7.5M | $53.5M | 2026-09-22 |
| AKKARAJU SRINIVAS | Director | $45.6M | $0 | 2025-09-04 |
| Rodman David Malcom | Other C-suite | $0 | $20.0M | 2026-08-10 |
| Congleton Jon | CEO | $105.6K | $19.3M | 2026-09-30 |
| Levy Adam Scott | CFO | $100.0K | $9.2M | 2026-01-12 |
| HBM Healthcare Investments (Cayman) Ltd. | 10% owner | $5.0M | $0 | 2023-02-14 |
| Warren Eric | Other C-suite | $0 | $3.3M | 2026-09-21 |
| Gold Alexander M | Director | $0 | $1.6M | 2025-11-13 |
| Karydas Daphne | Director | $0 | $925.6K | 2026-09-15 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2025-03-13 | 3 | $29.1M | 58 | +12.6% (+18.3% raw) | -11.2% (+3.7% raw) | +173.5% (+202.9% raw) | closed |
| 2023-02-14 | 5 | $44.1M | 47 | -17.3% (-18.7% raw) | -16.1% (-12.6% raw) | -41.5% (-32.5% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.